|



Elliot L. Chaikof, MD, PhD
PDF
of Dr. Chaikof's CV
| Academic Appointments |
 |
Professor and John E. Skandalakis Chair of Surgery, Division of Vascular Surgery, Department of
Surgery, Emory University School of Medicine
|
|
 |
Chief, Division of Vascular Surgery and Endovascular Therapy, Emory University |
| Secondary Appointments |
 |
Professor (Adjunct), School of Chemical and Biomolecular Engineering,
Georgia Institute of Technology |
|
 |
Professor, Wallace H. Coulter Department of Biomedical Engineering, Emory University/Georgia
Institute of Technology |
|
 |
Faculty Member, Institute of Bioengineering and Biosciences, Georgia
Institute of Technology |
| Telephone |
 |
404.778.5451 (Clinical) |
 |
404.727.8413 (Academic) |
| Certifications |
 |
General Surgery |
 |
Vascular Surgery |
| Education |
 |
MD, Johns Hopkins University
School of Medicine, Class of 1982 |
|
 |
PhD, Chemical Engineering, Massachusetts
Institute of Technology, 1989 |
|
 |
Residency in General Surgery, Massachusetts
General Hospital and Harvard Medical School, 1982-1985, 1989-1991 |
|
 |
Residency
in Vascular Surgery, Emory University School of Medicine, completed
1992 |
| Honors and Awards |
 |
2008 John Mannick Visiting Professor in Surgery, Harvard Medical School |
|
 |
American Board of Surgery, Associate Examiner, Vascular Surgery, 2004, 2008 |
|
 |
Atlanta's Top Doctors, Atlanta Magazine, 2006-2008 |
|
 |
Best Doctors in America, Castle Connolly Guide, 2005-2008 |
|
 |
2003 Harvard-Longwood Visiting Professor in Surgery, Harvard Medical School |
|
 |
2002 Pacific Vascular Research Foundation Visiting Professor in Surgery, UC-San Francisco |
|
 |
Woodruff Fund Clinical Teaching Award in Surgery, Emory University, 2002 |
|
 |
Dean's Clinical Investigator, Emory University, 2000-2003 |
|
 |
E. J. Wylie Traveling Fellowship awarded for academic excellence in clinical and basic research, Society for Vascular Surgery, 1996-1997 |
|
 |
Faculty Fellowship Award, American College of Surgeons, 1994-1996 |
|
 |
Clinician-Scientist Award, American Heart Association, 1994-1999 |
|
 |
Young Investigator Award, American Heart Association, 1993 |
|
 |
Sigma Xi, Massachusetts Institute of Technology, 1988 |
|
 |
E. D. Churchill Surgical Research Fellowship, Massachusetts General Hospital, 1986-1987 |
|
 |
Alpha Omega Alpha, Johns Hopkins School of Medicine, 1982 |
|
 |
C. V. Mosby Scholarship Award, Johns Hopkins School of Medicine, 1982 |
|
 |
Henry Strong Denison Research Scholar, Johns Hopkins School of Medicine, 1981 |
|
 |
Phi Beta Kappa, Johns Hopkins University, 1979 |
|
 |
Ann Shepard Zoology Award, University College, University of Toronto, 1977 |
|
 |
Ann Shepard Biology Award, University College, University of Toronto, 1976 |
| Current Organizational Memberships |
 |
American
College of Surgeons, Fellow |
|
 |
American Institute of Medical and Biological Engineering, Fellow |
|
 |
American Society for Clinical Investigation |
|
 |
Southern Surgical Association |
|
 |
American Surgical Association |
|
 |
Southern Association for Vascular Surgery |
|
 |
Society of University Surgeons |
|
 |
International Society of Applied Cardiovascular
Biology, President-Elect |
|
 |
Society for Vascular Surgery: Nominating Committee, Advisory Committee to the President |
|
 |
American Vascular Association |
|
 |
Association of Program Directors in Vascular Surgery |
|
 |
Peripheral Vascular Surgery Society |
|
 |
Association for Academic Surgery |
|
 |
Georgia Surgical Society |
|
 |
Society for Clinical Vascular Surgery |
|
 |
Atlanta Vascular Society, President-Elect |
| Clinical Interests |
 |
Endovascular treatment
of abdominal aortic aneurysms |
 |
Carotid
artery, renal artery and peripheral vascular arterial disease |
 |
Endovascular
surgery |
 |
Peripheral vascular disease |
 |
Venous diseases |
| Research Interests |
 |
Basic Science: The development of an advance generation of materials, devices and pharmacotherapeutics based upon the principles of biomimetics, molecular engineering and nanofabrication technologies for the treatment of vascular disease. The ultimate goal is to provide component building blocks for enabling advances in cell-based therapies, artificial organs and engineered living tissues, thereby contributing to the evolving field of regenerative therapies for vascular disease. |
|
 |
Clinical Research: Dr. Chaikof has been the Emory PI for over 30 clinical trial protocols directed at studies of endovascular therapies for treatment of aortic aneurysms, carotid disease and peripheral arterial disease as well as novel biologics, gene therapy and tissue engineered products for the cure of venous and arterial disease. |
| Year Joined Emory as a Faculty Member |
 |
1992 |
return to top
|